NCT03589118

Brief Summary

Craving arises in response to an affective tone that is associated with perceptual representations of a sensory object, rather than directly in response to the object. The investigators presume that qi gong functions to decouple pleasant and unpleasant experience from habitual reactions by removing the affective bias that fuels such emotional reactivity. Qi gong training may specifically target the associated learning process with an emphasis on the critical link between affect and craving in an addictive loop.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
186

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2018

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 18, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 17, 2018

Completed
3 months until next milestone

Study Start

First participant enrolled

October 4, 2018

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

July 17, 2019

Status Verified

July 1, 2019

Enrollment Period

2.2 years

First QC Date

May 18, 2018

Last Update Submit

July 15, 2019

Conditions

Keywords

Substance AddictionCravingChinese MedecineQi GongPsychology

Outcome Measures

Primary Outcomes (1)

  • Variation of craving intensity

    Variation of craving intensity on a Vvisual aAnalogic sScale (VAS) between baseline and the end of the treatment. The intensity is measured by "not at all" (score of 0) and "craving as bad as it could be" or "the most I've ever felt " (maximum score of 10), self-completed by the respondent. The respondent is asked to place a line perpendicular to the VAS line at the point that represents his craving intensity. The score is determined by measuring the distance on the 10-cm line between the "no craving" anchor and the patient's mark.

    Change in VAS from baseline to 9 weeks treatment

Secondary Outcomes (9)

  • Evolution over time of craving intensity

    0 day, 3 days, 5 days, 3 weeks and 9 weeks post-baseline

  • Difference in treatment retention

    3 weeks and 9 weeks post-baseline

  • Evolution over time of total alcohol consumption

    0 day, 3 days, 5 days, 3 weeks and 9 weeks post-baseline

  • Evoluation over time of anxiety

    0 day, 3 days, 5 days, 3 weeks and 9 weeks post-baseline

  • Evolution over time of depression

    0 day, 3 days, 5 days, 3 weeks and 9 weeks post-baseline

  • +4 more secondary outcomes

Study Arms (2)

Qi Gong

EXPERIMENTAL

Qi gong sessions added to usual well defined medical and psychological support

Other: Qi Gong sessions

Control

NO INTERVENTION

Usual well defined medical and psychological support

Interventions

13 sessions of Qi Gong in a 9 weeks period

Qi Gong

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Meets DSM 5 criteria for alcohol use disorder and other substance use disorders
  • Alcohol is one of the major abused substances if using multiple substances
  • Severity of the disorder defines by the necessity of a complex withdrawal hospitalization.
  • Used alcohol in the 3 weeks before hospitalization
  • Seeks addiction treatment
  • Patient willing to adhere to the study protocol (e.g. attend all visits and follow-ups in the next 3 months).
  • Age ≥ 18
  • Negative pregnancy test (βHCG) for women of child bearing potential
  • Signed informed consent
  • Affiliation to the French health insurance (recipient or assign)
  • Oral and written comprehension of the french langage
  • Pose a current suicidal risk including active suicidal ideation and suicide attempt in the past 30 days
  • Non stabilized severe psychiatric comorbidities such as bipolar disorder, schizophrenia, … (at the investigator's discretion)
  • Pregnant or breastfeeding women
  • Decompensated cirrhosis, liver encephalopathy, neurological complications, severe cognitive impairment and any other severe somatic comorbidity (at the investigator's discretion)
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Hôpital Saint ELOI

Montpellier, 34000, France

RECRUITING

Hôpital L'ARCHET

Nice, 06002, France

ACTIVE NOT RECRUITING

Groupe Hospitalier Pitié Salpêtrière

Paris, 75013, France

RECRUITING

MeSH Terms

Conditions

AlcoholismSubstance-Related Disorders

Condition Hierarchy (Ancestors)

Alcohol-Related DisordersChemically-Induced DisordersMental Disorders

Study Officials

  • Alain BAUMELOU, MD, Ph.D

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR
  • Nathalie PLET, Ph.D

    Assistance Publique - Hôpitaux de Paris

    STUDY DIRECTOR

Central Study Contacts

Alain BAUMELOU, MD, Ph.D

CONTACT

Nathalie PLET, Ph.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Primary outcome (VAS scale) will be presented to the patient and reported by a study nurse blinded of the randomization arm of the patient.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients are randomized in two groups : * usual medical and psychological support in the control group * qi gong sessions added in the experimental group Allocation between groups qi and control is 1 : 1
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 18, 2018

First Posted

July 17, 2018

Study Start

October 4, 2018

Primary Completion

December 1, 2020

Study Completion

December 1, 2020

Last Updated

July 17, 2019

Record last verified: 2019-07

Locations